Table 3 N-2-Arylation of various tetrazoles with boronic acidsa
applications in a broad range of areas related to N-heterocycles.
A detailed mechanistic study as well as the precise design and
synthesis of a compound library containing tetrazole motifs
aimed at the development of new drug is currently underway.
Financial support from Hundred Talent Program and
Academy-Locality Cooperation Program of CAS, and State
Key Laboratory of Fine Chemicals (KF1008) is acknowledged.
Notes and references
1 R. N. Butler, in Comprehensive Heterocyclic Chemistry, ed. A. R.
Katritzky, C. W. Rees and E. F. V. Scriven, Pergammon, Oxford, UK,
1996, vol. 4.
2 For examples: (a) A. D. Bond, A. Fleming, F. Kelleher, J. McGinley
and V. Prajapati, Tetrahedron, 2006, 62, 9577; (b) R. J. Herr, Bioorg.
Med. Chem., 2002, 10, 3379.
a
Reaction conditions: tetrazole 1 (0.5 mmol, 1.0 eq.), boronic acid 2
(1.0 mmol, 2.0 eq.), O2 (1 atm), and Cu2O (5 mol%) in DMSO (4 mL)
3 M. A. Hiskey, D. Chavez, D. L. Naud, S. F. Son, H. L. Berghout
and C. A. Bolme, Proc. Int. Pyrotech. Semin., 2000, 27, 3.
4 For some recent examples, see: (a) A. S. Gundugola, K. L. Chandra,
E. M. Perchellet, A. M. Waters, J.-P. H. Perchellet and S. Rayat,
Bioorg. Med. Chem. Lett., 2010, 20, 3920; and references cited
therein; (b) P. Srihari, P. Dutta, R. S. Rao, J. S. Yadav,
S. Chandrasekhar, P. Thombare, J. Mohapatra, A. Chatterjee and
M. R. Jain, Bioorg. Med. Chem. Lett., 2009, 19, 5569; and references
cited therein.
5 (a) Y. Wang, W. Song, W. J. Hu and Q. Lin, Angew. Chem., Int.
Ed., 2009, 48, 5330; (b) W. Song, Y. Wang, J. Qu, M. M. Madden
and Q. Lin, Angew. Chem., Int. Ed., 2008, 47, 2832; (c) W. Song,
Y. Wang, J. Qu and Q. Lin, J. Am. Chem. Soc., 2008, 130, 9654;
(d) Y. Wang, W. J. Hu, W. Song, R. K. V. Lim and Q. Lin, Org.
Lett., 2008, 10, 3725.
6 F. Chen, C. Qin, Y. Cui and N. Jiao, Angew. Chem., Int. Ed., 2011,
50, 11487, and extensive references therein.
7 (a) Z. P. Demko and K. B. Sharpless, Angew. Chem., Int. Ed., 2002,
41, 2110; (b) Z. P. Demko and K. B. Sharpless, Angew. Chem., Int.
Ed., 2002, 41, 2113.
8 (a) L. E. Kaim, L. Grimaud and P. Patil, Org. Lett., 2011, 13, 1261;
(b) Q. Tang and R. Gianatassio, Tetrahedron Lett., 2010, 51, 3473.
9 (a) Y. Wang and Q. Lin, Org. Lett., 2009, 11, 3570; (b) S. Ito,
Y. Tanaka, A. Kakehi and K. Kondo, Bull. Chem. Soc. Jpn., 1976,
49, 1920.
10 Indeed, the Cu(OAc)2-catalyzed coupling of N–H free 5-phenyl
tetrazole and boronic acid has been investigated. However, only a
poor yield of lower than 26% was obtained in the presence of 1.5
equivalents of Cu(OAc)2, various bases, and bubbling of O2, see:
P. Y. S. Lam, C. G. Clark, S. Saubern, J. Adams, M. P. Winters,
D. M. T. Chan and A. Combs, Tetrahedron Lett., 1998, 39, 2941.
11 (a) I. P. Beletskaya, D. V. Davydov and M. S. Gorovoy, Tetrahedron
Lett., 2002, 43, 6221; (b) D. V. Davydov, I. P. Beletskaya, B. B. Semenov
and Y. I. Smushkevich, Tetrahedron Lett., 2002, 43, 6217.
12 Y. Li, L.-X. Gao and F.-S. Han, Chem.–Eur. J., 2010, 16, 7969.
13 Cu salts: Cu(OAc)2, Cu(acac)2, Cu(OTf)2, CuCl2, CuI, CuBr,
CuCl, Cu2O, CuO; oxidants: PIFA, PIDA, m-CPBA, BPO, O2;
base: pyridine, Et3N, DBU, DABCO, and some inorganic bases;
solvent: (CH2)2Cl2, THF, MeOH, DMF, DMAc, DMSO.
14 CCDC 848060 contains the supplementary crystallographic data of
compound 3a.
at 100 1C; isolated yield.
Concerning the reaction mechanism of this transformation,
our results by using CuO (entries 8 and 9 in Table 1) as well as
10
a previous report by using Cu(OAc)2 as catalysts clearly
showed that these CuII catalysts are less effective in driving the
direct cross-coupling of N–H free tetrazole and boronic acids.
On the other hand, we have also demonstrated that CuI itself is
also an inactive metal center since only poor yield of the
product was obtained when the reaction was carried out under
a N2 atmosphere even in the presence of 50 mol% of Cu2O
(100 mol% Cu center) (entry 6 in Table 1). X-Ray photoelectron
spectroscopic (XPS) analysis of the recovered catalyst showed that
the CuI species remained unchanged with only negligible CuII
species observed under the N2 atmospheric conditions.18 In
contrast, both CuI and CuII existed in the recovered catalyst
when the reaction was performed under an O2 atmosphere,
and the coupled product 3a was obtained in 95% yield
(Table 1, entry 4). While an excellent yield was obtained in
this case, it does not mean the coupling reaction proceeds via a
CuI/CuII or Cu0/CuII cycle because neither CuI nor CuII is the
active metal center in this coupling reaction as demonstrated
by the control experiments.
Thus, a CuIII species may be serving as the active metal
center to drive the catalytic cycle. Indeed, such species has also
been proposed in some other Cu-catalyzed C–N or C–O bond
formations.16,19 However, there are no sufficient data at the
present stage to support that the CuIII intermediate is really
formed in the catalytic cycle although extensive experiments
were carried out. Therefore, a clear mechanistic elucidation for this
effective transformation deserves further detailed investigation by
designing some special experiments.
15 T. Kinzel, Y. Zhang and S. L. Buchwald, J. Am. Chem. Soc., 2010,
132, 14073; and references therein.
In summary, we have achieved successfully the direct coupling
of N–H free tetrazoles with low toxic boronic acids for the
synthesis of 2,5-disubstituted tetrazoles via the Cu2O-catalyzed
aerobic oxidative reaction. Moreover, only 5 mol% of cheap
Cu2O and environmentally benign O2 at 1 atm were required for
effective coupling. The by-products generated are low toxic
boronic acids. In addition, the protocol also exhibits excellent
functional group compatibility. Consequently, this protocol
represents very few examples for facile, universally applicable,
atom-efficient, and clean synthesis of 2,5-disubstituted tetrazoles.
We believe that the method presented herein would find extensive
16 For an example, see: G. C. H. Chiang and T. Olsson, Org. Lett.,
2004, 6, 3079.
17 For some representative examples, see: (a) C. A. Bernhart, P. M.
Perreaut, B. P. Ferrari, Y. A. Muneaux, J.-L. A. Assens, J. Clement,
´
F. Haudricourt, C. F. Muneaux, J. E. Taillades, M.-A. Vignal,
J. Gougat, P. R. Guiraudou, C. A. Lacour, A. Roccon, C. F.
Cazaubon, J.-C. Breliere, G. L. Fur and D. Nisato, J. Med. Chem.,
1993, 36, 3371; (b) P. Buhlmayer, P. Furet, L. Criscione, M. de Gasparo,
¨
S. Whitebread, T. Schmidlin, R. Lattmann and J. Wood, Bioorg. Med.
Chem. Lett., 1994, 4, 29.
18 See ESIw for XPS analysis.
19 A. E. King, T. C. Brunold and S. S. Stahl, J. Am. Chem. Soc., 2009,
131, 5044.
c
This journal is The Royal Society of Chemistry 2012
Chem. Commun., 2012, 48, 2719–2721 2721